Skip to main content

Year: 2021

Fortinet Unifies Zero Trust, Endpoint, and Network Security to Lead the Work-from-Anywhere Era

Fortinet is the Only Vendor Able to Deliver Contextual Security, Access, and Networking Based on Location SUNNYVALE, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) — John Maddison, EVP of Products and CMO at Fortinet“Empowering users to move seamlessly between different work environments has critical implications for maintaining user productivity as well as security. Cybercriminals have been quick to exploit the expanded attack surface and security gaps created by this shift in work patterns to get a foothold into the corporate network. Today’s enterprise organizations require work-from-anywhere security that is as flexible and dynamic as today’s business demands. Fortinet is the only vendor capable of delivering unified security built for the Work-from-Anywhere Era that seamlessly adapts based on a user’s environment and risk profile.” News...

Continue reading

Next Generation of Verisk Rating Solution Can Boost Insurers’ Efficiency and Speed to Market

New Cloud-Based Version of ISO Electronic Rating Content (ERC) Enables Commercial Lines Insurers to More Quickly and Easily Use the Latest ISO Loss Costs, Rules and Coverage Updates JERSEY CITY, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) — Responding to a deep industry need for speed and efficiency, Verisk (Nasdaq:VRSK), a leading global data analytics provider, has launched a new cloud-based version of its ISO Electronic Rating ContentTM (ERCTM) solution that can dramatically reduce the time and effort that commercial lines insurers spend updating rating content. The next generation of ERC is cloud-based and accessible via smart APIs. It is also significantly easier for insurers to use, integrate and test. The solution includes multiple deployment options to satisfy insurers’ diverse needs, including:Rating-as-a-Service...

Continue reading

Fulgent Genetics Offers Multi-Omic Solutions to Pharma through Addition of Olink Proteomics Platform

Strategic Partnership creates an end-to-end multi-omics platform for pharma, clinical research and biomarker discovery leveraging Fulgent’s expansive test menu across genomics, transcriptomics, and now, Olink Proteomics. TEMPLE CITY, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) — Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “Company”), a technology-based genetic testing company focused on transforming patient care in oncology, infectious and rare diseases, and reproductive health, and Olink Proteomics AB (NASDAQ: OLK) today announced the launch of a strategic partnership offering Olink assays through Fulgent’s CLIA certified labs in California and China. Through this partnership, Olink Proteomics has designated Fulgent as a certified provider of its full-suite of Olink products. With the addition of Olink technology, Fulgent...

Continue reading

DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania

ROCHESTER, N.Y., Nov. 04, 2021 (GLOBE NEWSWIRE) — DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business segments in blockchain security, direct marketing, healthcare, consumer packaging, real estate, renewable energy, and securitized digital assets, today announced its majority-owned subsidiary, American Medical REIT Inc. (“AMRE“), has acquired three hospitals (the “Hospitals”) located in Fort Worth, Texas, Plano, Texas and Pittsburgh, Pennsylvania. The aggregate purchase price for the Hospitals was $62 million. The Hospitals are currently tenanted and operated by LifeCare Hospitals (together with its affiliates, “LifeCare Hospitals”), a specialty hospital operator with a focus on long-term acute and critical care. The Hospitals acquired by AMRE are currently under an 18-year...

Continue reading

RespireRx Pharmaceuticals Inc. Announces Video Interview of CFO 

Glen Rock, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) — RespireRx Pharmaceuticals Inc. (OTCQB: RSPI), (“RespireRx” or the “Company”) a leader in the discovery and development of innovative and revolutionary treatments to combat diseases caused by disruption of neuronal signaling, is pleased to announce the public availability of a video interview of its Senior Vice President, Chief Financial Officer, Treasurer and Secretary, Jeff Margolis, by ProActive Investors. On Thursday, November 4, 2021, a recorded video interview of Jeff Margolis will be available for viewing by the general public by following this link: https://youtu.be/tCvvUlN7N7M. The interview will appear on the Proactive Investors website homepage throughout the day on Thursday, November 4, 2021 at www.proactiveinvestors.com and thereafter on the Proactive Investors website...

Continue reading

Conduent Named a Leader in 2021 ISG Provider Lens™ Contact Center – Customer Experience Services Reports

Company noted for Customer Experience capabilities and services in Digital Operations, AI/Analytics, Work from Home, Social Media CX FLORHAM PARK, N.J., Nov. 04, 2021 (GLOBE NEWSWIRE) — Conduent Incorporated (Nasdaq: CNDT) today announced Information Services Group (ISG), a leading global technology research and advisory firm, has recognized the company as a “Leader” in their 2021 ISG Provider Lens™ Contact Center – Customer Experience Services Global report. ISG’s 2021 reports evaluated the contact center – customer experience services of 28 companies in four categories – Digital Operations, AI/Analytics, Work from Home, and Social Media CX – across the U.S, UK/Europe and Globally. Conduent was named a leader in all four categories in the United States, and across multiple categories globally. The report defines “Leaders”...

Continue reading

Pure Extracts Receives Re-Order from Abba Medix Medical Platform for Vapes and Edibles

VANCOUVER, British Columbia, Nov. 04, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufacturing Corp., has received a re-order from Canada House Wellness Group’s (CSE: CHV) wholly owned subsidiary, Abba Medix Corp. (“Abba”) for vapes and gummies for sale to their established medical patient base. Included in the re-order are several SKUs of our Pure Pulls branded line of full spectrum oil (FSO) THC vape products and our blister-packaged gummie products, including our high potency 50 mg CBD Pure Chews. Pure Extracts’ CEO, Ben Nikolaevsky, commented,...

Continue reading

Evolve Reports New Employment Inducement Awards Under NYSE American Listing Rules

HOUSTON, Texas, Nov. 04, 2021 (GLOBE NEWSWIRE) — Evolve Transition Infrastructure LP (“Evolve”) (NYSE American: SNMP), a publicly traded limited partnership focused on the acquisition, development and ownership of infrastructure critical to the transition of energy supply to lower carbon sources, today reported, as required by Section 711(a) of the NYSE American Company Guide (the “Company Guide”), equity inducement awards to each of Randall Gibbs, Mike Keuss, and Jonathan Hartigan.   Messrs. Gibbs, Keuss, and Hartigan will accept employment with Evolve Transition Infrastructure GP LLC, the sole general partner of Evolve (the “General Partner”), effective November 3, 2021. Effective December 1, 2021, Mr. Gibbs will serve as the new Chief Executive Officer of the General Partner, Mr. Keuss will serve as the new President and Chief...

Continue reading

Foresight Enterprise VCT plc – Intention to launch an Offer

FORESIGHT ENTERPRISE VCT PLCLEI: 213800MWJNR3WZZ3ZP42 Intention to launch an Offer The board of Foresight Enterprise VCT plc is pleased to announce that it intends to launch an offer for subscription to raise up to £20 million (with an over-allotment of up to £10 million) through the issue of new ordinary shares. The prospectus, which will contain full details and the terms and conditions of the Offer, is expected to be available in January 2022. For further information, please contact: Company SecretaryForesight Group LLP Contact: Gary Fraser Tel: 0203 667 8100 Investor RelationsForesight Group LLPContact: Ellie Kakoulli Tel: 0203 667 8181

Continue reading

GreenBox POS Appoints Paul Levine as Chief Executive Officer & Co-Founder of Coyni Stablecoin Spinoff

SAN DIEGO, CA , Nov. 04, 2021 (GLOBE NEWSWIRE) — GreenBox POS (NASDAQ: GBOX) (“GreenBox” or the “Company”), an emerging financial technology company leveraging proprietary blockchain security and token technology to build customized payment solutions, announced the appointment of Paul Levine to the position of Chief Executive Officer & Co-Founder for its Coyni Stablecoin spinoff company. Paul Levine is a successful entrepreneur and technology innovator with 30 years’ experience in payments with both Fortune 100 and startup companies. He has led or worked with payments teams pioneering digital signature capture, electronic PC capture, wireless card acceptance, on-board cruise line acceptance, and revolutionizing China’s largest card schemes online cross-border acceptance. Since 2010 Paul has served as...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.